ArticleComputational and structural biotechnology journal2024
iResNetDM: An interpretable deep learning approach for four types of DNA methylation modification prediction.
Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prediction of DNA N4-Methylcytosine Sites Based on a Position-Aligned Multi-branch Fusion Network.Computational and structural biotechnology journal · 2026Article
- iDNA-DAPHA: a generic framework for methylation prediction via domain-adaptive pretraining and hierarchical attention.Briefings in bioinformatics · 2025Article
- PlantDeepMeth: A Deep Learning Model for Predicting DNA Methylation States in Plants.Plants (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Although several computational methods for predicting DNA methylation modifications have been developed, two main limitations persist: 1) All of the models are currently confined to binary predictors, which merely determine the presence or absence of DNA methylation modifications and thus prevent comprehensive analyses of the interrelations among varied modification types. Multi-class classification models for RNA modifications have been developed, and a comparable approach for DNA is essential. 2) Few previous studies offer adequate explanations of how models make decisions, instead relying on the extraction and visualization of attention matrices, which have identified few motifs and do not provide sufficient insights into the model decision-making process. Result: In this study, we introduce the task of DNA methylation modification prediction as a multi-class classification problem for the first time. We present iResNetDM, a deep learning model that integrates Residual Networks (ResNet) with self-attention mechanisms. To the best of our knowledge, iResNetDM is the first model capable of distinguishing between four types of DNA methylation modifications. Our model not only demonstrates good performance across various DNA methylation modifications but can also capture relationships between different types of modifications. We used the integrated gradients technique to enhance the interpretability of the iResNetDM. This method can effectively elucidate the model's decision-making process, thus enabling the successful identification of multiple motifs. Notably, our model displays remarkable robustness, and can effectively identify unique motifs across different methylation modifications. We also compared the motifs discovered in various modifications and found that some had notable sequence similarities, suggesting that they may be subject to different types of modifications. This finding highlights the potential importance of these motifs in gene regulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.